Koite Health is thrilled to announce its successful fundraising round, raising €793,000 to further revolutionize dental care across Europe. As a pioneering Finnish health tech company, Koite Health has already made significant strides in transforming oral hygiene with its innovative product, Lumoral®. This breakthrough, advanced, and patented medical device is designed to treat and prevent oral diseases by supplementing daily tooth brushing routines. Backed by rigorous scientific development, Lumoral® boasts an established antibacterial effect, making it particularly beneficial for individuals battling cavities or gum disease. Recognized as a class II medical and CE-approved device, Lumoral® has gained widespread acclaim and already enjoys a rapidly growing base of satisfied customers across Finland and beyond.
The funds raised will be strategically directed toward scaling operations, expanding product distribution throughout Europe, and intensifying research initiatives to enhance Lumoral®’s efficacy further. With a dedicated team composed of industry veterans boasting decades of experience in medical, pharmaceutical, marketing, and clinical research sectors, Koite Health is well-equipped to navigate the evolving healthcare landscape. Additionally, the company’s scientific board, featuring internationally recognized dental professors and researchers, plays a pivotal role in guiding product innovation and rigorous clinical validation.
This funding milestone not only underscores investor confidence in Koite Health’s groundbreaking approach to dental care but also sets the stage for new advancements that could redefine oral hygiene practices. As the company continues to grow, it remains committed to improving global dental health by delivering advanced, effective, and accessible solutions through its flagship product, Lumoral®. The future of dental care is bright, and Koite Health is proud to be leading the charge.
